Clinical Trials Browser

OTHER × Interventional × Infliximab × Clear all

NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Phase 2 Active not recruiting

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04407247 2025-12-23

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Phase 1/2 Active not recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Melanoma, Urogenital Neoplasms

NCT00463580 2025-07-08

Infliximab

Phase 4 Completed

60 enrolled 15 charts

Bipolar Disorder, Depression, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant

NCT02638701 2025-07-08

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Phase 1/2 Recruiting

Aneurysm, Vasculitis, Stroke

NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Phase 2 Recruiting

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

NCT01793519 2024-02-28

STARA

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

NCT04082910 2022-04-13

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Phase 1/2 Unknown

Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms

NCT02457585 2017-05-15

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Phase 2 Unknown

Takayasu Arteritis

NCT02126020 2017-04-07

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Phase 1/2 Withdrawn

Pemphigoid, Benign Mucous Membrane, Stevens-Johnson Syndrome, Syndrome

NCT00040885 2016-12-07

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Phase 3 Completed

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

NCT01295151 2016-11-02

SWITCH

Phase 4 Completed

Arthritis, Rheumatoid

NCT00228839 2009-06-30

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

Phase 1 Completed

Graft vs Host Disease

NCT00432406 2009-03-11

Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

Phase 4 Completed

Arthritis, Psoriatic